No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides—a cross-sectional analysis with dose–response analyses

OBJECTIVE: To investigate whether methotrexate (MTX) use is associated with bone mineral density (BMD) in patients with polymyalgia rheumatica (PMR) and various forms of vasculitis. METHODS: Rh-GIOP is a cohort study designed to evaluate bone health in patients with inflammatory rheumatic diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Palmowski, Andriko, Akahoshi, Mitsuteru, Muche, Burkhard, Boyadzhieva, Zhivana, Hermann, Sandra, Terao, Chikashi, Wiebe, Edgar, Buttgereit, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073043/
https://www.ncbi.nlm.nih.gov/pubmed/36811660
http://dx.doi.org/10.1007/s00296-023-05286-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073043/
https://www.ncbi.nlm.nih.gov/pubmed/36811660
http://dx.doi.org/10.1007/s00296-023-05286-6

Ejemplares similares